We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+34.98%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$376M
AUM Growth
-$31.2M
Cap. Flow
-$73.1M
Cap. Flow %
-19.42%
Top 10 Hldgs %
14.32%
Holding
275
New
96
Increased
11
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
BLU
BELLUS Health Inc.
BLU
+$6.2M
2
PI icon
Impinj
PI
+$5.08M
3
HLIT icon
Harmonic Inc
HLIT
+$4.59M
4
EXTR icon
Extreme Networks
EXTR
+$3.71M
5
PLMR icon
Palomar
PLMR
+$3.42M

Sector Composition

Rank Sector Weight
1 Healthcare 33.5%
2 Technology 16%
3 Industrials 11.73%
4 Energy 11.68%
5 Consumer Staples 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
51
Sarepta Therapeutics
SRPT
$1.77B
$2.26M 0.6%
+20,473
New +$2.06M
CNCE
52
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.26M 0.6%
337,095
-51,635
-13% -$313K
NSSC icon
53
Napco Security Technologies
NSSC
$1.45B
$2.25M 0.6%
+77,353
New +$2.07M
SRTS icon
54
Sensus Healthcare
SRTS
$50.7M
$2.2M 0.58%
175,257
NFE icon
55
New Fortress Energy
NFE
$97.8M
$2.16M 0.57%
49,473
-7,054
-12% -$354K
FSLR icon
56
First Solar
FSLR
$25.3B
$2.16M 0.57%
+16,297
New +$1.75M
CALX icon
57
Calix
CALX
$2.48B
$2.13M 0.57%
+34,850
New +$1.86M
AMAL icon
58
Amalgamated Financial
AMAL
$1.48B
$2.1M 0.56%
93,126
CORT icon
59
Corcept Therapeutics
CORT
$12.4B
$2.08M 0.55%
+81,268
New +$2.17M
RYAN icon
60
Ryan Specialty Holdings
RYAN
$10.9B
$2.08M 0.55%
51,157
+6,122
+14% +$258K
AXNX
61
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.07M 0.55%
+29,369
New +$2.03M
IMXI icon
62
International Money Express
IMXI
$358M
$2.07M 0.55%
90,702
-15,777
-15% -$371K
IRDM icon
63
Iridium Communications
IRDM
$5.24B
$2.07M 0.55%
+46,576
New +$2.02M
NXST icon
64
Nexstar Media Group
NXST
$5.87B
$2.07M 0.55%
12,380
HURN icon
65
Huron Consulting
HURN
$2.44B
$2.05M 0.54%
30,909
CPRX
66
DELISTED
Catalyst Pharmaceutical
CPRX
$2.04M 0.54%
159,290
-86,686
-35% -$1.03M
WSC icon
67
WillScot Mobile Mini Holdings
WSC
$4.36B
$2.04M 0.54%
+50,592
New +$1.97M
ADMA icon
68
ADMA Biologics
ADMA
$2.21B
$2.03M 0.54%
836,323
KNSL icon
69
Kinsale Capital Group
KNSL
$8.41B
$2.03M 0.54%
+7,952
New +$1.98M
SANM icon
70
Sanmina
SANM
$10.9B
$2.03M 0.54%
44,027
AVTA
71
DELISTED
Avantax, Inc. Common Stock
AVTA
$2.02M 0.54%
+104,626
New +$2.1M
VRN
72
DELISTED
Veren
VRN
$2.02M 0.54%
326,547
-246,454
-43% -$1.76M
INSW icon
73
International Seaways
INSW
$4.52B
$2.01M 0.53%
57,231
-12,640
-18% -$350K
SLP icon
74
Simulations Plus
SLP
$371M
$1.97M 0.52%
+40,628
New +$2.37M
ERII icon
75
Energy Recovery
ERII
$418M
$1.96M 0.52%
+90,216
New +$2.03M

Similar funds

EAM Global Investors's Q3 2022 Portfolio in Review

As of Q3 2022, EAM Global Investors held 275 positions worth $376M, down 7.7% from $407M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

EAM Global Investors withdrew a net $73.1M in Q3 2022, closing 103 positions and reducing 42 holdings. Its most notable exit was FLEX LNG, an estimated $7.59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Global Investors opened a new position in BELLUS Health Inc. worth $6.19M.

  • EAM Global Investors's largest Q3 2022 buy was BELLUS Health Inc.: 583,593 shares worth $6.19M.
  • EAM Global Investors added most to e.l.f. Beauty in Q3 2022, an estimated $2.46M increase.
  • EAM Global Investors's biggest Q3 2022 reduction was BancFirst, cutting an estimated $2.31M.
  • EAM Global Investors fully exited FLEX LNG in Q3 2022, selling an estimated $7.59M.
  • EAM Global Investors's ten largest holdings make up 14% of its $376M portfolio in Q3 2022.
  • EAM Global Investors opened 96 new positions and closed 103 in Q3 2022.
  • EAM Global Investors's portfolio value fell 7.7% quarter-over-quarter to $376M.

Based on EAM Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.